Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

STLNSTLN
Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in Starling Oncology, Inc.

Yes. Bank of America holds 391,997 shares of STLN (Starling Oncology), worth $2.1M, as of its Q2 2026 13F filing. It increased the position from 63,439 shares in Q1 2026. Bank of America has held STLN in every 13F on record since Q4 2022, 15 quarterly filings.

Current Value

$2.1M

Current Shares

391,997

Total Value Change

+$2.1M

Total Shares Change

+389,290

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
391,997
+517.9%
$2.1M0.0%$5.43
42
2026-Q1
Increased
63,439
+36.6%
$194,7580.0%$3.07
20
2025-Q4
Decreased
46,448
-10.2%
$165,3540.0%$3.56
0
2025-Q3
Increased
51,724
+100.4%
$180,5170.0%$3.49
25
2025-Q2
Increased
25,808
+779.9%
$52,9060.0%$2.05
23
2025-Q1
Increased
2,933
+0.5%
$3,3430.0%$1.14
9
2024-Q4
Increased
2,918
+7.8%
$9020.0%$0.31
8
2024-Q3
Increased
2,707
+1.4%
$8820.0%$0.33
8

Other major holders of STLN: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used